【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Injectable drug delivery market – Industry Summary and Key Buying Criteria, 2013 – 2024
Chapter 3. Injectable Drug DeliveryIndustry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2013 – 2024
3.3. Injectable drug delivery: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Escalation in demand for self- injection devices
3.3.1.2. Increase in number of chronic diseases
3.3.1.3. Innovative technological progress
3.3.1.4. Development of the biologics market
3.3.2. Market restraint analysis
3.3.2.1. Needle stick injuries and infections
3.3.2.2. Preference over other drug delivery systems
3.3.2.3. Sterility of injectables
3.4. Injectable drug delivery market: Industry trend analysis
3.5. Injectable drug delivery market – PESTEL Analysis
3.6. Injectable drug delivery Industry analysis – Porter’s Five Forces Model
3.7. Injectable drug delivery: Company Market Share Analysis (%), 2015
3.8. Key opportunities prioritized
Chapter 4. Injectable Drug Delivery Product Type Outlook
4.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Product Outlook, 2016 & 2024
4.2. By Devices
4.2.1. Self-injection devices
4.2.1.1. Self-injection devices market revenue, by region, 2013 to 2024 (USD Million)
4.2.2. Conventional devices
4.2.2.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3. By Formulations
4.3.1. Conventional drug delivery
4.3.1.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3.2. Novel drug delivery
4.3.2.1. Novel drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.4. Others
4.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 5. Injectable Drug Delivery Therapeutic Use Outlook
5.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Therapeutic Use Outlook, 2016& 2024
5.2. Autoimmune disorders
5.2.1. Autoimmune disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.3. Hormonal disorders
5.3.1. Hormonal disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.4. Oncology
5.4.1. Oncology injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.5. Others
5.5.1. Others drug injectable drug delivery market, by region, 2013 to 2024 (USD Million)
Chapter 6. Injectable Drug Delivery End-User Application Outlook
6.1. Injectable Drug Delivery Revenue Share (%) Analysis, by End-User Application, 2016& 2024
6.2. Hospital
6.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
6.3. Homecare Settings
6.3.1. Homecare settings market revenue, by region, 2013 to 2024 (USD Million)
6.4. Others
6.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 7. Injectable Drug Delivery Regional Outlook
7.1. Injectable drug delivery Market Share (%) Analysis, by Region, 2013&2024
7.2. North America
7.2.1. U.S.
7.2.1.1. U.S. injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.1.2. U.S injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.1.3. U.S. injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.2.1.4. U.S. injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.2.2. Canada
7.2.2.1. Canada injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.2.2. Canada injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.2.3. Canada injectable drug delivery market, by therapeutic use,2013 – 2024 (USD Million)
7.2.2.4.Canada injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3. Europe
7.3.1. Germany
7.3.1.1. Germany injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.1.2. Germany injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.3.1.3. Germany injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.1.4. Germany injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3.2. UK
7.3.2.1. UK injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.2.2. UK injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.3.2.3. UK injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.2.4. UK injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4. Asia-Pacific
7.4.1. China
7.4.1.1. China injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.1.2. China injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.4.1.3. China injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.4.1.4. China injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4.2. India
7.4.2.1. India injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.2.2. India injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.4.2.3. India injectable drug delivery market, by therapeutic use 2013 – 2024 (USD Million)
7.4.2.4. India injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.5. MEA
7.5.1. South Africa
7.5.1.1. South Africa injectable drug delivery market, by device, 2012 – 2024 (USD Million)
7.5.1.2. South Africa injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.1.3. South Africa injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.1.4. South Africa injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.5.2. Saudi Arabia
7.5.2.1. Saudi Arabia injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.5.2.2. Saudi Arabia injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.2.3. Saudi Arabia injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.2.4. Saudi Arabia injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Brazil injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.6.1.2. Brazil injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.1.3. Brazil injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.1.4. Brazil injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.6.2. Mexico
7.6.2.1. Mexico injectable drug delivery market, by device,2013 – 2024 (USD Million)
7.6.2.2. Mexico injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.2.3. Mexico injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.2.4. Mexico injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
Chapter 8. Competitive Landscape
8.1. Pfizer, Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Baxter International, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Schott AG
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Becton, Dickinson and Company
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. ELI Lily and Company
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Alkermes PLC
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Terumo Corporation
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8 Elcam Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9 Unilife Corporation
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：注射薬物送達の世界市場の収益分析：機器別（自己注射機器、従来の機器）、処方別（従来型薬物送達、新規型薬物送達）、治療使用方法別（自己免疫疾患、ホルモン障害、腫瘍学）、エンドユーザー用途別（病院、ホームケア施設、研究機関、臨床検査室）、地域別（アメリカ、カナダ、ドイツ、英国、中国、インド、南アフリカ、サウジアラビア、ブラジル、メキシコ）、セグメント予測、2013-2024■ 英文：Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user Application (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region (U.S, Canada, Germany, U.K, China, India, South Africa, Saudi Arabia, Brazil, Mexico) And Segment Forecasts From 2013 to 2024
■ 発行日：2016年8月11日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707435
■ 調査対象地域：グローバル
- 世界の抗菌薬市場（2014-2024）Antibacterials - new analysis showing business trends, R&D, and revenue forecasts What's the future of medicines treating bacterial infections? For those drugs you get new sales predictions, also exploring research and development. Those treatments hold high potentials. There you assess results, progress, therapies, and opportunities. Knowledge facilitates success. Visiongain's new report forecast …
- 多発性神経炎（多発性ニューロパチー）治療のグローバル臨床試験動向（2014年下半期）Polyneuropathies Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Polyneuropathies Global Clinical Trials Review, H2, 2014" provides data on the Polyneuropathies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polyneuropathies. It includes an overview of the trial numbers and their recruitment statu …
- 世界のバンカシュランス市場調査：Global Bancassurance Market 2014-2018TechNavio's analysts forecast the Global Bancassurance market to grow at a CAGR of 5.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the enhanced product portfolio for banks and the resulting increase in profitability. The Global Bancassurance market has also been witnessing the increasing participation of foreign private insurance players in banc …
- 廃炉の世界市場：PWR原子炉、BWR原子炉、PHWR原子炉、LWGR原子炉、GCR原子炉Technavio’s research analyst predicts the global nuclear decommissioning market to grow at a CAGR over 2% during the forecast period. Fatal accidents such as the Chernobyl and Fukushima incidents have propelled the growth of this market. This has resulted in an increase in the decommissioning of nuclear plants across the globe. For instance, during 2011, Germany decided to phase out all its operat …
- バイオバンクの世界市場予測2016-2026Biobanks – How to Discover Trends, R&D and Sales Forecasts from 2016, Helping Your Influence Are you interested in the future of medical biobanking? If so, you can now gain technological and commercial predictions from 2016. That way you stay ahead for data, benefiting your authority. There explore trends in research and development, results, opportunities and revenue forecasts. That new study by …
- 世界のBFSI（銀行・金融サービス・保険）セキュリティ市場：物理的セキュリティ、サイバーセキュリティOver the last few decades, the operating environment of BFSI industry has changed significantly in terms of technological advancements and work flow processes. There has been continuous technological revolution in the banks and financial institutions in the form of ATMs, core banking, e-banking, mobile banking, and consequently many services came into existence such as Real Time Gross Settlement ( …
- Google in RFID and M2MRFID and M2M represent two large markets by themselves, both expected to grow dramatically over the next 10-20 years. Mix this growth with the competencies and expected continued growth of Google and there is a powerful mixture for explosive growth. This research includes an evaluation of RFID and M2M from a state of the industry perspective. This research identifies areas in which Google is poise …
- ビジネスジェットの世界市場2016-2020About Business Jets A business jet is an aircraft that is designed to transport small number of passengers. The travel prices for business jets are significantly higher than that of commercial airliners. These jets are usually owned and operated by corporations, individuals, government agencies, or commercial business jet operators that provide business jet charter services. Schemes such as Jet Ca …
- メキシコの心臓律動管理（CRM）装置市場見通しMexico Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "Mexico Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the Mexico Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronisation Therapy (CRT …
- データセンターコロケーションサービスの世界市場The colocation market has gained major importance due to the explosion of internet-based services and cloud based networking services. The colocation service includes power, cooling and physical security for the server, storage, and networking equipment and allowing enterprises to connect to a network service provider of their choice. The enterprises are continuously trying to run data centers in …
- 自動車用排気ガス再循環装置（EGRシステム）の世界市場About Automotive EGR Systems market An EGR system helps recirculate gases from the exhaust system in an automotive engine. The EGR system valve opens when it encounters pressure from a vehicle's exhaust and sends back the exhaust gas into the combustion chamber. The primary function of an EGR system is to reduce the combustion temperature of the fuel in an automotive engine, and thus reduce produc …
- Colazal & Giazo(潰瘍性大腸炎)：市場分析と予測（～2022）Colazal & Giazo (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event a …
- 世界の液体ポンプおよび液体エレベーター市場（～2019）The expansion of the global liquid pump and elevator industry is forecast to reach 3.5% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 6.1%. Currently, pumps dispensing lubricants and fuel in filling stations account for 1.1% of the global demand while the remaining market share is divided between other pumps fitted with a measuring device (1. …
- イヤホン･ヘッドホンの世界市場分析：製品別（耳内、オーバーイヤー）、技術別（ワイヤー式、ワイヤレス）、価格別（50未満、50～100、100以上）、用途別（フィットネス/スポーツ、ゲーム、VR、音楽）、セグメント予測、2014-2025The global earphones and headphones market is expected to reach USD 15.8 billion by 2025, according to a new research conducted by Grand View Research, Inc. The increasing adoption of earphones/headphones during a workout is primarily expected to drive the earphones & headphones market growth over the coming years. Customers use headphones at their workplaces to enjoy music and other audio content …
- グローバルスープ市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global soups market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global soups market throughout the month. Additionally, the report provides an overview of all the partnering, al …
